All > Diabetes Type 2

Sequence A for Type 2 Diabetes

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Novo Nordisk Investigational Site, Cypress, CAType 2 Diabetes+1 MoreSemaglutide B, 1.34 mg/mL - Drug
Eligibility
18 - 55
All Sexes
What conditions do you have?
Select

Study Summary

This trial studies two drug concentrations of semaglutide for the treatment of type 2 diabetes. Participants will get two injections with the drug, and must agree to not get vaccinations during the study period. Women cannot take part if pregnant or breast-feeding.

Eligible Conditions
  • Type 2 Diabetes
  • Healthy Subjects

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
AC-OLE-01-VA
1
dMAb AZD8076
1
Part A: Oral semaglutide

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: 0-840 hours after a single dose of s.c. semaglutide 0.5 mg

Hour 840
AUC0-last,sema 0.5mg: Area under the semaglutide concentration time curve from time 0 until last quantifiable measurement after single dose of subcutaneous semaglutide 0.5 mg
Cmax,sema,0.5mg: maximum observed semaglutide concentration-time after single dose of subcutaneous semaglutide 0.5 mg administration

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
AC-OLE-01-VA
1
dMAb AZD8076
1
Part A: Oral semaglutide

Trial Design

2 Treatment Groups

Sequence A
1 of 2
Sequence B
1 of 2

Experimental Treatment

20 Total Participants · 2 Treatment Groups

Primary Treatment: Sequence A · No Placebo Group · Phase 1

Sequence AExperimental Group · 2 Interventions: Semaglutide B, 1.34 mg/mL, Semaglutide B, 0.68 mg/mL · Intervention Types: Drug, Drug
Sequence BExperimental Group · 2 Interventions: Semaglutide B, 1.34 mg/mL, Semaglutide B, 0.68 mg/mL · Intervention Types: Drug, Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Semaglutide B, 1.34 mg/mL
2022
Completed Phase 1
~20

Trial Logistics

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 0-840 hours after a single dose of s.c. semaglutide 0.5 mg

Who is running the clinical trial?

Novo Nordisk A/SLead Sponsor
1,424 Previous Clinical Trials
2,313,648 Total Patients Enrolled
Clinical Transparency dept. 2834Study DirectorNovo Nordisk A/S
27 Previous Clinical Trials
508,361 Total Patients Enrolled

Eligibility Criteria

Age 18 - 55 · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have used illegal drugs or abused prescription medications within the last year.
Your body mass index (BMI) falls between 20.0 and 29.9 kilograms per meter square (kg/m^2).
Both males and females are eligible.
You regularly consume more than 24 grams of alcohol per day (for men) or 12 grams of alcohol per day (for women) within the last year.
References

Frequently Asked Questions

What type of participant would be most suitable for this research endeavor?

"Applicants to this study must have type 2 diabetes and be between the ages of 18-55. To date, 20 individuals are being sought for enrolment in the trial." - Anonymous Online Contributor

Unverified Answer

Has Sequence A been approved by the US Food and Drug Administration?

"Owing to the limited data available, Sequence A received a score of 1 in regards to safety from our experts at Power. This is consistent with its Phase 1 status, which suggests there are only preliminary results regarding both safety and efficacy." - Anonymous Online Contributor

Unverified Answer

Are geriatric individuals excluded from this research protocol?

"Eligibility requirements for this study necessitate that potential participants are between 18 and 55. There are 95 trials specifically aimed at minors, while 1006 exist to help seniors manage their medical conditions." - Anonymous Online Contributor

Unverified Answer

Is this experiment presently enrolling participants?

"As per details stored on clinicaltrials.gov, this particular trial is not actively seeking subjects. This study was initially posted on January 13th 2023 and has since been updated on the 9th of that same month; however, 1557 other studies are presently accepting participants." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top